In our experiments, we used an anti-pan-Akt antibody (Akt 1/2/3); therefore, we cannot rule out the possibility that the observed changes in the MetS condition are associated with diminished expression or activity of a specific Akt isoform. This evidence concerns the gene AKT1 and metabolic syndrome.